Color
Color provides genetic testing services and a virtual cancer clinic, offering at-home screening and oncologist-led care for various health conditions.
Secondary Market Price
How Color Measures Up
To help you manage your Color equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series E
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Color's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Color Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Color's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Color is a healthcare technology company focused on cancer care. The company provides services across the cancer journey, including at-home screenings based on National Comprehensive Cancer Network guidelines, support for active treatment, and survivorship care. Its model uses an oncologist-led clinical team to identify and manage high-risk members, with the stated goals of improving access, reducing time to diagnosis, and closing clinical care gaps. Founded in 2014 and headquartered in Burlingame, California, Color initially centered on genomics and genetic testing before expanding into its current, broader focus on cancer care delivery for employers and health plans.
The company's recent activities suggest a continued expansion of its virtual cancer care model through new partnerships. Color recently announced a collaboration with Evry Health to provide its Virtual Cancer Clinic to Evry's members. The company also supports large-scale research, including the University of California, San Francisco's WISDOM Study on risk-based breast cancer detection. In its 2025 Impact Report, Color reported metrics such as a 77% increase in screening adherence and a 55% reduction in the time to diagnosis and treatment among its user base.
- General Catalyst
- Khosla Ventures
- 8VC
- Emerson Collective
- T. Rowe Price
- Viking Global Investors
- Kindred Ventures
- BlackRock
- Co-Founder, Othman Laraki
- Co-Founder, Elad Gil
- Co-Founder, Nish Bhat
- Co-Founder, Taylor Sittler
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Color worth joining?
Deciding to join a private company like Color requires a careful look at your total compensation, especially the long-term potential of your equity grant. Tools like Prospect can help you model different financial scenarios and understand the potential future value of your stock options.
What should I do with my Color stock?
Managing stock in a private company like Color involves complex decisions around when to exercise options and how to plan for taxes. Using a platform like Prospect can provide you with customized, tax-optimized strategies to help you maximize the value of your equity.
Can you sell Color stock?
As a private company, selling your Color stock is typically possible only during specific liquidity events, such as a tender offer or on a secondary market. Prospect offers tools to help you navigate these opportunities and determine which shares are the most tax-optimal to sell.
How can I find the value of my Color stock?
The value of private company stock like Color's is determined by internal 409A valuations and is not publicly listed. To get a better sense of its potential future worth, you can use Prospect's predictive models to forecast your equity's value.
What is Color's equity worth?
The exact worth of Color's equity fluctuates and depends on factors like the company's latest 409A valuation, performance, and market conditions. Financial modeling tools from Prospect can help you project your net equity value based on various growth scenarios and tax implications.
What is Color's stock ticker symbol?
As a privately held company, Color does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell Color stock?
Buying shares in a private company like Color is typically limited to accredited investors during specific funding rounds, while selling is usually restricted to company-approved tender offers. When an opportunity to sell arises, tender offer tools can help you make tax-optimized decisions on how much to sell.
What is the criteria to buy or invest in Color stock?
Investing in a private company like Color is generally reserved for accredited investors who are invited to participate in private funding rounds. For employees who already have equity, the focus is less on buying more and more on managing what you have, which is where platforms like Prospect provide value.
